News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,310 Results
Type
Article (42218)
Company Profile (296)
Press Release (670796)
Section
Business (210323)
Career Advice (2090)
Deals (36620)
Drug Delivery (105)
Drug Development (82975)
Employer Resources (172)
FDA (16537)
Job Trends (15385)
News (355794)
Policy (33864)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2582)
Accelerated approval (2)
Adcomms (21)
Allergies (80)
Alliances (51335)
ALS (77)
Alzheimer's disease (1339)
Antibody-drug conjugate (ADC) (106)
Approvals (16521)
Artificial intelligence (224)
Autoimmune disease (10)
Automation (14)
Bankruptcy (367)
Best Places to Work (11771)
BIOSECURE Act (19)
Biosimilars (98)
Biotechnology (190)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (234)
Cancer (1813)
Cardiovascular disease (140)
Career advice (1746)
Career pathing (29)
CAR-T (132)
Cell therapy (377)
Cervical cancer (13)
Clinical research (66920)
Collaboration (712)
Compensation (389)
Complete response letters (24)
COVID-19 (2640)
CRISPR (36)
C-suite (180)
Cystic fibrosis (100)
Data (1714)
Decentralized trials (2)
Denatured (24)
Depression (38)
Diabetes (225)
Diagnostics (6385)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (106)
Drug pricing (106)
Drug shortages (26)
Duchenne muscular dystrophy (63)
Earnings (87386)
Editorial (29)
Employer branding (21)
Employer resources (148)
Events (114027)
Executive appointments (601)
FDA (17514)
Featured Employer (54)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (634)
Gene editing (90)
Generative AI (20)
Gene therapy (270)
GLP-1 (696)
Government (4486)
Grass and pollen (4)
Guidances (45)
Healthcare (18969)
Huntington's disease (23)
IgA nephropathy (20)
Immunology and inflammation (95)
Indications (24)
Infectious disease (2760)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (71)
Interviews (322)
IPO (16745)
IRA (47)
Job creations (4054)
Job search strategy (1491)
Kidney cancer (9)
Labor market (26)
Layoffs (464)
Leadership (15)
Legal (8358)
Liver cancer (69)
Lung cancer (261)
Lymphoma (121)
Machine learning (2)
Management (58)
Manufacturing (254)
MASH (59)
Medical device (13367)
Medtech (13372)
Mergers & acquisitions (20265)
Metabolic disorders (597)
Multiple sclerosis (58)
NASH (17)
Neurodegenerative disease (72)
Neuropsychiatric disorders (25)
Neuroscience (1780)
NextGen: Class of 2025 (6635)
Non-profit (4524)
Northern California (2214)
Now hiring (35)
Obesity (329)
Opinion (221)
Ovarian cancer (62)
Pain (78)
Pancreatic cancer (69)
Parkinson's disease (118)
Partnered (17)
Patents (182)
Patient recruitment (79)
Peanut (48)
People (58878)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20749)
Phase II (29450)
Phase III (22061)
Pipeline (806)
Podcasts (69)
Policy (111)
Postmarket research (2654)
Preclinical (8775)
Press Release (68)
Prostate cancer (85)
Psychedelics (31)
Radiopharmaceuticals (247)
Rare diseases (348)
Real estate (6248)
Recruiting (66)
Regulatory (22844)
Reports (43)
Research institute (2363)
Resumes & cover letters (358)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (66)
Series A (116)
Series B (69)
Service/supplier (12)
Sickle cell disease (52)
Southern California (1894)
Special edition (14)
Sponsored (29)
Startups (3719)
State (2)
Stomach cancer (12)
Supply chain (56)
The Weekly (44)
United States (19520)
Vaccines (643)
Venture capitalists (34)
Webinars (12)
Weight loss (232)
Women's health (30)
Worklife (13)
Date
Today (184)
Last 7 days (824)
Last 30 days (2938)
Last 365 days (34907)
2025 (5649)
2024 (35771)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (780)
Alabama (48)
Alaska (7)
Arizona (218)
Arkansas (13)
Asia (40436)
Australia (6477)
California (5043)
Canada (1766)
China (423)
Colorado (232)
Connecticut (239)
Delaware (113)
Europe (86193)
Florida (742)
Georgia (172)
Idaho (57)
Illinois (475)
India (21)
Indiana (281)
Iowa (7)
Japan (130)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (774)
Massachusetts (3867)
Michigan (203)
Minnesota (347)
Mississippi (2)
Missouri (70)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1430)
New Mexico (28)
New York (1436)
North Carolina (881)
North Dakota (7)
Northern California (2214)
Ohio (176)
Oklahoma (13)
Oregon (37)
Pennsylvania (1144)
Puerto Rico (6)
Rhode Island (23)
South America (1159)
South Carolina (13)
South Dakota (1)
Southern California (1894)
Tennessee (83)
Texas (740)
Utah (157)
Virginia (124)
Washington D.C. (54)
Washington State (485)
West Virginia (3)
Wisconsin (46)
713,310 Results for "tonix pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference
February 5, 2025
·
8 min read
Press Releases
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
February 4, 2025
·
10 min read
Press Releases
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
February 3, 2025
·
9 min read
Press Releases
Tonix Pharmaceuticals to Present at Two Upcoming January 2025 Investor Conferences
January 8, 2025
·
5 min read
Press Releases
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
February 7, 2025
·
11 min read
Pharm Country
Tonix Pharmaceuticals Announces Proposed Public Offering - June 26, 2024
Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company, announced that it intends to offer and sell shares of its common stock.
June 26, 2024
·
5 min read
Press Releases
Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference
November 26, 2024
·
5 min read
Pharm Country
Tonix Pharmaceuticals Announces Proposed Public Offering - June 11, 2024
Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company, announced that it intends to offer and sell shares of its common stock.
June 11, 2024
·
5 min read
Deals
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - June 26, 2024
Tonix Pharmaceuticals Holding Corp. today announced that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
June 26, 2024
·
4 min read
Pharm Country
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Jessica Morris, Chief Operating Officer, will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, Calif.
May 28, 2024
·
4 min read
1 of 71,331
Next
